Alix Marduel Corcept Therapeutics Inc
As of November 13, 2008
What is Alix Marduel's Net Worth?
The current estimated net worth of Corcept Therapeutics Inc's Alix Marduel is estimated to be about $94.09M . Alix Marduel owns about 166,491 units of Corcept Therapeutics Inc common stock. In the last 4 years at Corcept Therapeutics Inc, Alix Marduel has sold an estimated value of $0 worth.
What is Alix Marduel's Past Insider Trading?
Alix Marduel's largest purchase order was 1,059,135 units , worth over $2.93M on March 26, 2008. In total, Alix Marduel has made about 7 transactions over 4 years of their time at Corcept Therapeutics Inc. Alix Marduel usually trades in August and April, with the busiest year in 2007.
ALTA BIOPHARMA PARTNERS II LP, ALIX MARDUEL, JEAN DELEAGE, FARAH CHAMPSI, ALTA BIOPHARMA MANAGEMENT II LLC, ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC, ALTA PARTNERS II INC
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Alix Marduel's' Mailing Address?
- Mailing address is One Embarcadero Center Suite 3700 San Francisco CA 94111 CA
Corcept Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Joseph K. Belanoff, M.D., | 2020 | $769,567 | $744,000 | $4,237,643 | $10,892 | $5,762,102 |
| Joseph K. Belanoff, M.D., | 2019 | $707,525 | $745,290 | $3,506,155 | - | $4,958,970 |
| Joseph K. Belanoff, M.D., | 2018 | $679,792 | $477,750 | $5,157,075 | - | $6,314,617 |
| Andreas Grauer, M.D., | 2020 | $454,550 | $219,157 | $1,271,293 | $118,274 | $2,063,274 |
| Andreas Grauer, M.D., | 2019 | $362,267 | $243,720 | $3,115,335 | $78,245 | $3,799,567 |
| Hazel Hunt, Ph.D., | 2020 | $431,873 | $243,000 | $2,084,640 | - | $2,759,513 |
| Sean Maduck, | 2020 | $474,380 | $214,157 | $2,508,404 | - | $3,196,941 |
| Sean Maduck, | 2019 | $456,133 | $308,881 | $1,476,276 | - | $2,241,290 |
| Sean Maduck, | 2018 | $436,667 | $198,000 | $2,171,400 | - | $2,806,067 |
| Charles Robb, | 2020 | $474,380 | $321,236 | $2,118,822 | - | $2,914,438 |
| Charles Robb, | 2019 | $456,133 | $308,881 | $1,845,345 | - | $2,610,359 |
| Charles Robb, | 2018 | $436,667 | $237,600 | $2,171,400 | - | $2,845,667 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm
What are Corcept Therapeutics Inc's Past Insider Trades?
Corcept Therapeutics Inc's most recent insider trade came on May 19, 2022 by Gary Charles who sold 35,000 units worth $684.4K . In the last 18 years, insiders at Corcept Therapeutics Inc have sold an estimated value of $166.04M and bought an estimated value of $184.22M worth of shares. Insider trading is most common in February, with the busiest year in 2006. The most active traders at the company are Joseph K Belanoff, Chief Executive Officer, Robert Roe, President and Secretary, and Leonard Baker Jr, Director .
CORCEPT THERAPEUTICS INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||